Tumor infiltration by CD8+ T cells was equivalent in lean and obese mice with B16 melanoma, but CD8+ TIL in obese mice displayed lower effector activity and this was associated with poor tumor control even after ICB immunotherapy. The gene discussed is CD8A; the disease is neoplasm.